Global Clinical Trial Supplies Market – Industry Trends and Forecast to 2027

  • Healthcare
  • Published Report
  • Nov 2020
  • Global
  • 350 Pages
  • No of Tables: 162
  • No of Figures: 64

Global Clinical Trial Supplies Market, By Services (Storage, Manufacturing, Packaging and Labelling, Distribution), Clinical Phase (Phase III, Phase II, Phase IV, Phase I), Therapeutic Uses (Oncology, Cardiovascular Disease, Dermatology, Metabolic Disorders, Infectious Diseases, Respiratory Diseases, CNS and Mental Disorders, Blood Disorders, Others), End User (Contract Research Organizations, Pharmaceutical and Biotechnology Companies), Country (U.S., Canada, Mexico, Belgium, Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Rest of Europe, Japan, China, South Korea, India, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Clinical Trial Supplies MarketMarket Analysis and Insights : Global Clinical Trial Supplies Market

The clinical trial supplies market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.8% in the forecast period of 2020 to 2027 and is expected to reach USD 4,843.55 million by 2027. The rising demand in clinical trials worldwide is the factor leading the growth of the clinical trial supplies market in future.

The clinical trial is a research study that determines whether a medical strategy, treatment or device is safe, effective and useful for humans use. These studies help in finding which medical approach experiment is the best for certain diseases. A clinical trial provides the best data for health care decision-making purposes. The purpose of clinical trials is to study strict scientific standards. These standards protect patients and help in producing reliable study results. Clinical trials are last stage in drug development in a long and careful research process that is carried out by scientists or researchers for a particular disease, whether drug or medical device. The process of drug development often begins in a lab, where scientists first develop and test new ideas related to treatment of disease.

The high number of cases is leading to new drug developments that can help in treatment of various disorders. This will create clinical trial supplies requirements in each of the pharma and biotech industries and thus the clinical trial supplies market will likely to grow due to increase in various problems related to health in forecasted timeframe. The clinical trials also possess disadvantages with negative effects on human which may leads to death of the people and can resist growth of the clinical trial supplies market.

The rising population and high prevalence of diseases is also leading the supply with higher growth rate worldwide acting as an opportunity for the clinical trial supplies market. Despite of high time and cost investments for developing biologics and new drug, it is estimating that lower procedure time and rate for approval of drug is creating the biggest challenge for the clinical trial supplies market.

The clinical trial supplies market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, products approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the clinical trial supplies market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Clinical Trial Supplies MarketClinical Trial Supplies Market Scope and Market Size

The clinical trial supplies market is categorized based on services, clinical phase, therapeutic uses and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of services, the global clinical trial supplies market is segmented into storage, manufacturing, packaging and labelling and distribution. In 2020, storage segment in global clinical trial supplies market is expected to grow due to direct-to-site shipment approach, as well as mixed alternatives combining central and local depots of clinical supplies in the global clinical trial supplies market.
  • On the basis of clinical phase, the global clinical trial supplies market is segmented into phase III, phase II, phase IV and phase I. In 2020, phase III segment in global clinical trial supplies market is expected to grow because it requires thousands of people to perform experiments and these experiments goes for longer period of time which further needs more supplies and services in various pharma companies and contract research organizations (CROs).
  • On the basis of therapeutic uses, the global clinical trial supplies market is segmented into oncology, cardiovascular disease, dermatology, metabolic disorders, infectious diseases, respiratory diseases, CNS and mental disorders, blood disorders and others. In 2020, oncology segment in global clinical trial supplies market is expected to grow because of the increasing number of patients with cancer, along with this, the research on cancer in clinical trials is also rising significantly.
  • On the basis of end user, the global clinical trial supplies market is segmented into contract research organizations and pharmaceutical and biotechnology companies. In 2020, contract research organizations segment in global clinical trial supplies market is expected to grow because most of the clinical trial experiments performed for medicines such as drugs or medical devices are used for the treatment of diseases by contract research organizations (CROs).

Clinical Trial Supplies MarketGlobal Clinical Trial Supplies Market Country Level Analysis

The global clinical trial supplies market is analysed and market size information is provided by country, services, clinical phase, therapeutic uses and end user as referenced above.

The countries covered in the global clinical trial supplies market are the U.S., Canada, Mexico, Belgium, Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Rest of Europe, Japan, China, South Korea, India, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa and Rest of Middle East and Africa.

Asia-Pacific region is likely to dominate the global clinical trial supplies market due to new drug development and rising clinical trials in the developing areas. China is dominating in the Asia-Pacific clinical trial supplies market because of availability of the personalized medicines helping in diagnosis and treatment of various diseases and also helping the growth of clinical trial supplies in many of the biotechnology and pharmaceutical companies. The U.S. is dominating in the North America clinical trial supplies market as the supply chain management of the country includes manufacturing, storage, distributing, logistics, shipping and other vital parts. The various key units such as manufacturing, packaging, pharmacy, quality, and regulatory, clinical, analytics are all associated with clinical supply chain. Whereas, Germany is dominating in the Europe clinical trial supplies market due to increasing population with such disease treatment. The country’s personalized medicines deliver success in targeted therapies especially in cancer and cystic fibrosis in patients that help developing clinical trial treatment in the above mention period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as sales, FDA approvals, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global branded and generic drug manufacturers and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Continuous Advancement in Technological Services is Propelling the Clinical Trial Supplies Market Growth

Global clinical trial supplies market also provides you with detailed market analysis for every country growth in installed base of different kind of products for clinical trial supplies market, impact of technology using life line curves and changes in infant formula regulatory scenarios and their impact on the clinical trial supplies market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Global Clinical Trial Supplies Market Share Analysis

Global clinical trial supplies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to clinical trial supplies market.

The major prominent participants operating in the global clinical trial supplies market report are Catalent, Inc., Almac Group, Biocair, SIRO Clinpharm Private Limited, Sharp, PCI Pharma Services, MYODERM, Clinigen Group plc., KLIFO, CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC., Bionical Ltd., Thermo Fisher Scientific Inc., Parexel International Corporation, Alium Medical Limited, Ancillare, LP and Movianto among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches, approvals, partnerships and agreements are also initiated by the companies’ worldwide which are also accelerating the global clinical trial supplies market.

For instance,

  • In August 2020, Thermo Fisher Scientific Inc. has launched a new site for manufacturing of COVID-19 sample collection products. The company has also announced that this site will continue to expand to meet expected sustained demand for COVID-19 clinical studies and testing. This step has helped the company in expanding their services and in meeting the necessary demands of the customers.

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for clinical trial supplies through expanded range of size.

Customization Available: Global Clinical Trial Supplies Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES 

TABLE 1 GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018 – 2027, (USD MILLION)

TABLE 2 GLOBAL STORAGE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, BY REGION , 2018-2027 (USD MILLION)

TABLE 3 GLOBAL MANUFACTURING CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, BY REGION, 2018-2027 (USD MILLION)

TABLE 4 GLOBAL PACKAGING AND LABELLING CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 GLOBAL DISTRIBUTION CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2018-2027 (USD MILLION)

TABLE 7 GLOBAL PHASE III CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 8 GLOBAL PHASE II CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 GLOBAL PHASE IV CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 GLOBAL PHASE I CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION)

TABLE 12 GLOBAL ONCOLOGY CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 GLOBAL CARDIOVASCULAR DISEASES CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 GLOBAL DERMATOLOGY CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 GLOBAL METABOLIC DISORDERS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 GLOBAL INFECTIOUS DISEASES CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 GLOBAL RESPIRATORY DISEASES CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 GLOBAL CNS AND MENTAL DISORDERS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 GLOBAL BLOOD DISORDERS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 GLOBAL OTHERS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 21 GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 22 GLOBAL CONTRACT RESAERCH ORGANIZATIONS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018 – 2027 (USD MILLION)

TABLE 25 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 26 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 27 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 28 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 29 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 30 U.S.CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 31 U.S.CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 32 U.S.CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 33 U.S.CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 34 CANADA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 35 CANADA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION)

TABLE 36 CANADA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 37 CANADA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 38 MEXICO CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 39 MEXICO CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION)

TABLE 40 MEXICO CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 41 MEXICO CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 42 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 43 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 44 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION)

TABLE 45 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 46 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 47 GERMANY CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 48 GERMANYCLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 49 GERMANYCLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 50 GERMANY CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 51 FRANCECLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 52 FRANCE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION)

TABLE 53 FRANCE CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 54 FRANCE CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 55 U.K. CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 56 U.K. CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 57 U.K. CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 58 U.K. CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 59 ITALY CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 60 ITALY CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 61 ITALY CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 62 ITALY CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 63 SPAIN CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 

(USD MILLION ) 115

TABLE 64 SPAIN CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 65 SPAIN CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION)

TABLE 66 SPAIN CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 67 NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 68 NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 69 NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 70 NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 71 RUSSIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 72 RUSSIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 73 RUSSIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 74 RUSSIACLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 75 BELGIUM CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 76 BELGIUM CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 77 BELGIUM CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 78 BELGIUM CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 79 TURKEY CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 80 TURKEY CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 81 TURKEY CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 82 TURKEYCLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 83 SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 84 SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 85 SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 86 SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 87 REST OF EUROPE ORECLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 88 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 89 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 90 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 91 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 92 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 93 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 

(USD MILLION ) 133

TABLE 94 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 95 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION)

TABLE 96 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 97 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 98 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 99 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION)

TABLE 100 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 101 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 

(USD MILLION ) 137

TABLE 102 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 103 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 104 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 105 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 106 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 107 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 108 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 109 AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 110 ASUTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 111 ASUTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 112 AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 113 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 114 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 115 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 116 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 117 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 118 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 119 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 120 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 121 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 122 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 123 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 124 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 125 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 126 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 127 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 128 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 129 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 130 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 131 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 132 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 133 REST OF ASIA-PACIFIC ORECLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 134 REST OF ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 135 REST OF ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 136 REST OF ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 137 SOUTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 138 SOUTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 139 SOUTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 140 SOUTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 141 SOUTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 142 BRAZIL CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 143 BRAZIL CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 144 BRAZIL CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION)

TABLE 145 BRAZIL CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 146 REST OF SOUTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 147 REST OF SOUTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 148 REST OF SOUTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 149 REST OF SOUTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 150 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 151 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 152 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 153 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 154 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 155 SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 156 SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 157 SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 158 SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 159 REST OF MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 160 REST OF MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 161 REST OF MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 162 REST OF MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions